Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.
Benmebarek MR, Karches CH, Cadilha BL, Lesch S, Endres S, Kobold S. · 2019
Read Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells. by Benmebarek MR, Karches CH, Cadilha BL, Lesch S, Endres S, Kobold S. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6470706.txt.
Description
Benmebarek and co-authors explain how CAR T cells kill, tracing the engineered receptor from target binding to tumor cell death. A single-chain antibody fragment gives the T cell its aim, free of the usual MHC restriction, and docking creates a non-classical immune synapse. What happens next decides whether the therapy works.
Killing runs mainly through perforin and granzyme release and through the Fas death pathway, while secreted cytokines sensitize the surrounding tumor stroma. Persistence and output hinge on the receptor's parts, its spacer and costimulatory domains, working together. Successes in blood cancers and failures in solid tumors frame the closing assessment of design choices.
Catalog record
| CREATOR | Benmebarek MR, Karches CH, Cadilha BL, Lesch S, Endres S, Kobold S. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |